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1. Introduction 
Neurofeedback is a technique to enable individuals to change their brain activity by using 
an instrument that provides information on the activity of the brain. The goal of 
neurofeedback is to improve behavioral or cognitive processes related to brain activity. The 
technique of neurofeedback, although available for some time, is rapidly gaining interest as 
a treatment of various disorders (Yucha & Montgomery, 2008). Recent evidence indicates 
that the technique may also be used beneficially for the treatment of autism spectrum 
disorders.  
Currently, the most frequent application of neurofeedback lies in the treatment of epilepsy 
and attention deficit hyperactivity disorder (ADHD). Epilepsy has been treated with 
neurofeedback since the 70s of the previous century. Epilepsy is a chronic neurological 
disorder characterized by abnormal, excessive or synchronous neuronal activity in the brain 
resulting in seizures. The main focus of neurofeedback in epilepsy is to enhance the 
sensorimotor rhythm (SMR) originating from the sensorimotor cortex of the brain. This 12 to 
15 Hz activity is involved in the inhibition and control of movement. Increased SMR is 
found to be related to improved movement inhibition and consequently offers protection to 
seizures in individuals with epilepsy (Sterman & Egner, 2006). Scientific studies that 
investigated the efficacy of neurofeedback in individuals with epilepsy were recently 
evaluated by Tan and colleagues (2009). They found that in a total of nine studies, 
neurofeedback was effective in reducing the number of seizures in 79% of participants with 
severe epilepsy who did not respond to medication. The number of sessions that was used 
in these studies varied from 24 to more than 200 sessions. It was concluded that 
neurofeedback is a promising treatment for individuals with severe epilepsy, but that future 
randomized, sham controlled studies are required to confirm the efficacy of neurofeedback 
(Tan et al., 2009). 
Most research on neurofeedback has been conducted in individuals with ADHD. ADHD is a 
developmental disorder characterized by inattention, hyperactivity and impulsivity 
(American Psychiatric Association, 2000). The EEG profiles of 85 to 90% of the individuals 
with ADHD show elevated theta power and reduced beta power over frontal and central, 
midline cortical brain areas (Monastra et al., 2005). Neurofeedback in ADHD aims to inhibit 
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theta power and to elevate beta power in these cases. A recent meta-analysis on the efficacy 
of EEG-biofeedback in ADHD (Arns, de Ridder, Strehl, Breteler, & Coenen, 2009) 
demonstrated large effects on clinical symptoms of inattention and impulsivity and a 
medium effect on symptoms of hyperactivity. These conclusions, however, are mainly based 
on studies that were non-randomized and used no blinding of participants. Therefore, a 
conclusion on the efficacy of neurofeedback in ADHD is still preliminary at this point.  
Neurofeedback has recently also been applied to individuals with autism. The term autism 
in this chapter refers to disorders of the entire autistic spectrum. The present chapter first 
provides an overview of the history of neurofeedback, followed by a detailed explanation of 
the practice of the technique as it is used in clinical practices. We furthermore describe what 
is known about working mechanisms that are involved in neurofeedback and provide an 
overview of the benefits of neurofeedback for individuals with autism. Finally, we review 
the existing literature on neurofeedback and autism and discuss several options for future 
research.   
2. The origin of neurofeedback 
The origin of neurofeedback goes back to the 1960s when Joseph Kamiya successfully 
trained human individuals to control alpha waves. Alpha waves are oscillations in the 8 to 
12 Hz frequency range that are predominantly generated in occipital and parietal lobes and 
can be recorded during wakeful relaxation with eyes closed. In the experiment by Kamiya, 
participants were instructed to indicate whether they thought they were ‘in alpha’, i.e. 
whether their brain produced alpha as the dominant frequency, or not each time a tone 
sounded. They received feedback on whether the answer was correct or not. Initially the 
participants answered correct in about fifty percent of the trials. After alpha training was 
provided, some participants developed the ability to recognize the alpha state and to answer 
correctly in most of the trials. In a second experiment, the same participants were asked to 
go into the alpha state when a tone sounded once and not to go into the alpha state when 
the tone sounded twice. Interestingly, Kamiya found that some participants were able to 
enter the alpha state on command, whereas others were not (Kamiya, 1968).  
Around the same time, Barry Sterman accidentally discovered the curative power of 
neurofeedback for patients with epilepsy. Sterman set up an experiment where he taught 
cats to produce 12 to 15 Hz oscillations along the sensorimotor cortex of the brain. He 
rewarded the cats with milk each time they produced 12 to 15 Hz oscillations and concluded 
that cats could learn to increase the sensorimotor rhythm (SMR). Increased SMR brought the 
motor suppression response under experimental control and helped to reduce muscle tone, 
reflex amplitudes, and cellular discharge in motor pathways. After this experiment ended, 
the cats were used for another experiment investigating the toxic symptoms of exposure to 
rocket fuel. Sterman’s cats turned out to be more seizure resistant than cats that had not 
received SMR training (Wyricka & Sterman, 1968). It took only a few years before Sterman 
treated the first human patients with epilepsy. These patients showed a reduction of 
electroencephalographic and clinical epileptic manifestations after three months of SMR 
training (Sterman, Macdonald, & Stone, 1974).  
Joel Lubar continued Sterman’s work and used SMR training in patients with ADHD to 
reduce hyperactivity. Lubar and Shouse (1976) reported the results of 142 neurofeedback 
sessions in an 11-year old boy with ADHD who was trained to enhance SMR and to reduce 
theta power. After several months, the boy showed less undirected activities, less out-of-seat 
www.intechopen.com
Neurofeedback Treatment 
for Autism Spectrum Disorders – Scientific Foundations and Clinical Practice 
 
103 
behavior, and less oppositional behaviors. In addition, there was increased cooperation and 
improvement in school work. In the reversal phase of the study, the boy’s behavior and 
school work were found to worsen and to improve again when the initial training was 
recommenced.  
Margaret Ayers, fascinated by the outcomes of these experimental studies, opened the first 
neurofeedback practice in 1975. One of her patients was Brian, a boy with severe epilepsy 
whose severe epilepsy significantly reduced after neurofeedback treatment. The parents of 
Brian, Siegfried and Sue Othmer, were impressed by the results of neurofeedback in their 
son. They started to promote neurofeedback in the United States of America. In 1987 they 
introduced a computerized neurofeedback tool and subsequently started a clinical practice 
for neurofeedback.  
After these initial cases, the application of neurofeedback in patients with epilepsy and 
ADHD further extended in the 90s of the previous century. Subsequently, neurofeedback 
has also been applied in healthy individuals and in patients with various other disorders 
like depression, learning disability, post traumatic stress disorder, traumatic brain injury, 
and autism spectrum disorders (see review in: Yucha & Montgommery, 2008).  
3. The practice of neurofeedback  
In a typical neurofeedback session, a client sits in front of a computer screen while his or her 
electroencephalographic (EEG) activity is recorded by one or more electrodes. Figure 1 
shows an example of the set up of a neurofeedback session in which a Nexus-4 device 
(MindMedia, the Netherlands) was used.  
 
 
Fig. 1. An example of the set up of a neurofeedback session. 
Before a client can commence with neurofeedback treatment, a treatment plan needs to be 
determined specifying the frequency component (or components) that is to be altered and 
the exact locations on the scalp at which training will take place.  In the field of 
neurofeedback, such a treatment plan is often referred to as a treatment protocol. The 
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components and locations for training of such a treatment protocol are typically determined 
by comparing a 19-channel EEG recording of the client with a normative database 
containing the EEG spectra of typically developing individuals of the same age.  
Typically, an EEG recording is collected using a stretchable electrode cap that contains 
multiple electrodes to map the distribution of brain waves over multiple sites on the scalp. 
Each of the electrodes is connected to the client’s scalp using a conductive electro gel. Figure 
2 shows an example of the experimental setup of an EEG assessment using the Mitsar EEG 
201 System (Mitsar Medical Diagnostic Equipment, Russia). Following the correct 
preparation of all electrodes in the cap, a client’s EEG is recorded for several minutes in one 
or more conditions. The conditions eyes opened and eyes closed are usually included in the 
EEG assessment. In these conditions, the client is instructed to sit still on a comfortable chair 
while keeping the eyes opened or closed. Next to the recording of EEG in these rest 
conditions, the EEG may be recorded in task conditions like reading or math.  
 
 
Fig. 2. An example of the set up of a 19-channel EEG assessment using the Mitsar EEG 201 
System.  
Raw EEG recordings are analyzed to construct a quantitative EEG (QEEG) containing the 
absolute and relative power spectra of the client’s EEG per electrode. Relative power 
expresses the ratio of power in a particular frequency band relative to the total power across 
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frequencies. The client’s absolute and relative QEEG data may be subsequently compared 
with a normative database containing EEG data of healthy individuals of the same age to 
estimate possible deviations from normality. Two databases that are often used are NxLink 
designed by John, Prischep, & Easton (NxLink, Ltd.) and NeuroGuide, designed by 
Thatcher (Applied Neuroscience, Inc.). These databases produce color-coded maps and data 
in digital format, providing information on a client’s deviations from the norm group. The 
output of such a database comparison may be used to guide the selection of the frequency 
components and the location for the subsequent neurofeedback treatment.   
Figure 3 shows part of the output of the NeuroGuide database revealed by comparing the 
QEEG of a 15-year old girl with Asperger disorder to this database. The maps indicate that, 
relative to the database, power in the theta range over central and frontal electrodes exceeds 
the population mean, i.e. a population of girls of the same age without an autism spectrum 
disorder, by more than one and a half standard deviations. As a consequence, 
neurofeedback might, in this case, target the inhibition of 3 to 7 Hz power over fronto-
central scalp regions. 
 
 
Fig. 3. An example of the output of a comparison between the QEEG of a 15-year old girl 
with Asperger disorder and the NeuroGuide database. Across fronto-central scalp sites a 
deviation of one and a half standard deviation is seen (color coded in red) of low frequency 
power in the 3-7 Hz frequency range compared to a norm group of girls with same age, 
without autism.  
In addition to the method of using a database to determine possible frequency components 
and locations for training, a neurofeedback protocol may also be specified by visual 
inspection of the raw 19-channel EEG recording of the client. This procedure requires 
extensive knowledge of the raw EEG. A raw EEG signal is composed of separate brain 
waves with different frequencies and amplitudes, often arranged in separate frequency 
bands, i.e. delta (1-3 Hz) theta (4-7 Hz), alpha (8-12 Hz), beta (13-30 Hz), and gamma (above 
30 Hz). These frequency bands can be identified in the raw EEG on the basis of the unique 
waveform patterns of each frequency band. Figure 4 shows an example of raw EEG data of a 
10-year old boy with PDD-NOS in WinEEG software (Mitsar Medical Diagnostic 
Equipment, Russia). This example includes raw EEG activity measured by electrodes across 
several frontal sites. Visual inspection of this EEG fragment reveals clear theta activity at 
electrode Fz, which is indicated by the black arrow.  
Instead of using individualized treatment plans wherein the frequency component and 
treatment location are determined on the basis of an individual’s EEG characteristics, 
neurofeedback treatment may also be guided by predefined treatment protocols. Probably 
          3 Hz                 4 Hz                 5 Hz                   6 Hz                  7 Hz                 8 Hz 
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Fig. 4. Raw EEG data of a 10-year old boy with PDD-NOS in WinEEG software. The black 
arrow indicates the theta activity that is observed at electrode Fz.    
the best known protocol is the theta/beta protocol that is used often in the treatment of 
ADHD. This protocol prescribes the decrease of theta power while beta power is increased 
at frontal or central, midline regions (Monastra et al., 2005). This protocol was developed 
after the finding that 85 to 90% of the individuals with ADHD have elevated theta power 
and reduced beta power over frontal and central, midline cortical regions of the brain 
(Monastra et al., 2005). Although the theta/beta protocol was originally applied to 
individuals with ADHD, this neurofeedback protocol has also been applied successfully to 
individuals with autism (Jarusiewicz, 2002; Kouijzer et al., 2009b; Scolnick, 2005; Sichel, 
Fehmi, & Goldstein, 1995; Thompson, Thompson, & Reid, 2010).  
After a treatment plan has been established, the actual neurofeedback treatment may 
commence. In each neurofeedback session, an electrode needs to be attached to the selected 
treatment location by using conductive electrode paste. In addition, reference and ground 
electrodes are to be attached. Often the reference electrode is located somewhere on the 
head at a location where little or no of the frequency component that is selected for 
treatment is found, e.g. at an earlobe or at the bone behind one of the ears, i.e. the mastoid. 
The ground electrode is typically placed somewhere on the body, e.g. at the mastoid. Figure 
5 provides an example of electrode configuration during a typical neurofeedback session, 
showing an EEG electrode that is used for feedback attached to the scalp (in red) and a 
reference electrode (in black) attached to the left mastoid.  
During a neurofeedback session, information about the level of EEG activity in the 
frequency component that was selected for training is fed back to the client. Although in 
principle feedback may take any form or modality, most neurofeedback therapists use a bar 
graph on the computer screen to reflect the ongoing changes in EEG power over time. 
Figure 6 shows an example of such a computer screen created with BioTrace software 
(MindMedia, the Netherlands). The larger the amplitude of the recorded EEG activity is, the 
higher the orange bar graph on the computer screen will be presented. In this way, the bar 
graph informs the client about the amplitude of his or her EEG activity, almost immediately 
after it occurs. A criterion line is drawn together with the bar graph representing a concrete 
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Fig. 5. Electrodes attached to the scalp and the mastoid during neurofeedback. 
goal for the trainee. That is, depending on the treatment plan (i.e. increase or decrease 
activation in a particular frequency range), the client may be directed at keeping the bar 
graph amplitude beneath or above the criterion line. At first, meeting the criterion is 
accidental, but over time participants may learn to maintain the bar graph below or above 
the indicated criterion. 
Whenever the client manages to keep the bar graph below or above the criterion line for a 
minimal amount of time, visual and auditory rewards may be provided, often in the form of 
a film clip presented next to the bar graph. Film clips are usually presented with 
corresponding music or sound and are chosen according to to the age and interests of the 
client. Clients can also be rewarded by a counter that counts the number of seconds the 
criterion is met. If desired, the bar graph can change color when the EEG activity is not 
within the desired range, or the film clip can shrink to remove the reward. Some clients with 
autism show resistance to the combination of many different rewards, such as a shrinking 
film clip, music, a counter, and a color changing bar graph. Therefore, the exact form in 
which the reward is presented should reflect the preferences of the client.  
A typical neurofeedback session consists of training and rest intervals. During training 
intervals, the client’s goal is to move the bar graph below or above a criterion line. These  
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Fig. 6. An example of a computer screen where the mean amplitude of the EEG frequency of 
interest is fed back to the client via an orange bar graph with a white criterion line. In 
addition, a film clip and a counter are shown as rewards for the client.  
training intervals are alternated with rest intervals, in which the client can relax for a short 
time. The length of the training intervals depends largely on the attention span of the client. 
Clients with a larger attention span may be presented with longer training intervals. A 
training interval of three minutes was chosen in several studies where neurofeedback was 
applied in children and adolescents with autism (e.g. Kouijzer et al., under review). If 
necessary, the length of training intervals may be adapted during the course of the training. 
Training and rest intervals are alternated manually or by predefined scripts. Clients with a 
high need for structure, like many clients within the autistic spectrum, might benefit from 
the accuracy that is provided by such a script.  
Neurofeedback training is usually provided in psychological practices and typically takes 
place twice or thrice per week. Some neurofeedback therapists provide home training 
programs. The number of sessions is determined by the specific complaints of the client and 
on the progression of the client during the training. Neurofeedback for individuals with 
autism generally includes at least 40 sessions. 
4. Cognitive and neuronal mechanisms underlying neurofeedback 
Although the number of publications on the effects of neurofeedback is growing, little has 
been written about the actual functional and neuronal mechanisms that may be involved in 
its application and its resulting effects. In this paragraph we present an overview of several 
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functional and neuronal mechanisms that may play a role in changing brain activation via 
neurofeedback and discuss why some individuals are responsive to the application of 
neurofeedback whereas others are not. We end with a discussion on possible neural 
mechanisms in autism that may be targeted by neurofeedback.  
4.1 Functional mechanisms underlying neurofeedback  
Operant conditioning involves a process of behavior modification whereby the 
consequences of an action determine the likelihood that the same action will be expressed in 
the future. Positively reinforced actions will be performed more frequently, whereas 
negatively reinforced behavior will fade out (Gazzaniga & Heatherton, 2003). Closely 
related to operant conditioning is Thorndike’s law of effect, stating that any behavior that 
leads to a satisfying state of affairs is more likely to occur again, and behavior that leads to 
an annoying state of affairs is less likely to occur again (Thorndike, 1933). The principles of 
operant conditioning are considered to be a major factor in the capacity of neurofeedback to 
effectuate changes in EEG. During a neurofeedback session, a client is rewarded each time 
he or she manages to move the bar graph on the computer screen below or above the 
criterion line. That is, a film clip turns on, music starts playing, or a counter starts running. 
Assuming that these rewards are satisfying to the client, chances increase that the patterns 
of EEG activity that preceded the reward are generated in the future. Vice-versa, brain 
activity that produces no rewarding effects will tend to fade away.  
Following the principles of operant conditioning, the EEG activity of most clients who take 
part in neurofeedback is found to change during consecutive neurofeedback sessions. 
Notwithstanding the success of neurofeedback training in some clients, often however, there 
is also a second group of clients whose EEG activity is not found to change over time, and 
for whom neurofeedback does not seem to work. These two groups of clients are referred to 
as responders to neurofeedback and non-responders to neurofeedback, respectively. 
Responders to neurofeedback are clients whose EEG activity successfully changes during 
neurofeedback sessions. In non-responders there is no significant change in EEG activity 
observed during the course of the neurofeedback sessions. Figure 7 shows examples of EEG 
activity of a responder and a non-responder to neurofeedback. Both clients were trained to 
reduce theta power in 40 consecutive neurofeedback sessions. The responder to 
neurofeedback shows a clear decrease of average theta power, whereas the non-responder 
does not show such a decrease.  
Response rates of neurofeedback in individuals with autism have been reported to vary 
between 54 and 76% (Coben & Padolsky, 2007; Kouijzer et al., 2009b; Kouijzer et al., 2010; 
Kouijzer et al., under review). This means that in more than half of the clients with autism 
who participated in a scientific study, EEG activity was successfully changed over the 
course of the neurofeedback treatment. At the same time, there is also a substantial group of 
clients that was unable to respond to neurofeedback over time. As such it may be interesting 
to speculate about the reasons why some individuals may turn out to be responsive to 
treatment with neurofeedback, whereas others may not. 
Although the reason why some participants respond to neurofeedback whereas others do 
not is unclear at this time, it may be that responders and non-responders differ on certain 
psychological dimensions such as differences in attention span, cognitive flexibility or 
sensitivity to reward. Alternatively, there might be physiological differences between 
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Fig. 7. Mean values of theta power of two clients who were trained to decrease theta power in 
40 consecutive neurofeedback sessions. The upper part of the figure shows the mean values of 
theta power per session of a responder to neurofeedback; the lower part of the figure displays 
the mean values of theta power per session of a non-responder to neurofeedback.   
responders and non-responders, for instance with regard to individual differences in QEEG 
profiles. Another possibility is that there may be differences between responders and non-
responders in terms of the amount and the quality of the rewards they received during the 
neurofeedback treatment. That is, most therapists adapt the rewards to what they think 
works best for the individual client, which might introduce differences in both the quantity 
and quality of rewards between clients. For example, it may be that some clients respond 
best if they receive rewards in 80% of the time, whereas other clients may need more 
challenge and only respond to conditions in which rewards are provided in 50% of the time, 
or less. Similarly, some clients may be more responsive to exciting film clips, whereas others 
may benefit more from quiet and highly structured film clips. Inadequate choices of the 
therapist might influence a client’s responsiveness to the treatment. A further understanding 
of individual preferences in both the amount and the type of rewards that are provided 
during neurofeedback is required to optimize the response rates of clients to neurofeedback 
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training. In addition, the application of neurofeedback as a treatment may benefit strongly 
from developing predictors, i.e. specific psychological or physiological differences between 
individuals that allow an early distinction between responders and non-responders, and 
thus to save time, effort, and money on treatment of non-responders.  
Whereas operant conditioning is generally considered to be a relatively passive process on 
which the trainee has little or no direct influence, learning processes during neurofeedback 
sessions might also be influenced by active processes. It is often reported that clients manage 
to develop deliberate control over their EEG activity, allowing them increase or decrease the 
height of the bar graph in a voluntary manner. There are also clients, however, who never 
gain deliberate control over their EEG activity. These clients might be responders to 
neurofeedback, but they can not intentionally act upon the EEG signal. Kamiya (1968) was 
to first to provide evidence for deliberate control over EEG activity. In his study, 
participants were first trained to produce alpha waves and some of them subsequently 
managed to recognize the state of  these alpha waves on instruction. Nowadays, the 
deliberate control over EEG activity is used frequently in clinical settings where patients 
with neuromuscular impairments or locked-in syndrome use brain computer interfaces 
(BCI) to control external devices. Birbaumer and colleagues (1999), for example, showed that 
paralyzed patients who completely lack muscular control can learn to communicate with 
their environment by using an electronic spelling device that is controlled by EEG activity. 
By intentionally activating EEG activity in a specific frequency range, a computer cursor is 
controlled to point out and select different letters of the alphabet to construct a message.  
The functional mechanisms that are used to control electrical activity of the brain in a 
deliberate way may not be so different from functional mechanisms that we use for 
controlling our body. A dominant theory in motor control is the Ideomotor Theory 
(Greenwald, 1970), which states that our actions are primarily controlled at the level of their 
sensory effects. For instance, when learning how to ride a bike, the motor system is 
attempting to match the anticipated visual and tactile consequences of the actions with an 
appropriate motor command. Development of new movement repertoire, e.g. in case 
children are learning how to drink from a cup without spilling its content, requires internal 
models that map the relation between sensory consequences and action output that need to 
be formed through experience. The ability to control one’s own brain waves may well 
operate on similar principles, whereby the trainee’s brain, over time, establishes the 
relationship between motor intentions and their sensory consequences, allowing an internal 
model to form and control the sensory effects that are provided by the neurofeedback. A 
simple experiment provides a convincing demonstration of this idea. Most people are 
unable to wiggle their ears but may easily learn to do so when the signal of the muscles 
controlling their ears is made explicit to them (Bair, 1901). You can try this yourself by 
putting your fingers behind your ears on the tendons that are controlling their movement. 
The direct sensory effect will make it much easier to establish control. In a sense, 
neurofeedback is no different from this example. All it does is make unconscious biological 
signals explicit to the client so that he or she may learn to control these signals in a 
deliberate manner.  
4.2 Neuronal mechanisms behind neurofeedback  
The exact cortical and subcortical mechanisms of the brain supporting neurofeedback 
training have received little or no attention so far, as have its neural effects. There is one 
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fMRI study that investigated the effects of neurofeedback on neural substrates in children 
with ADHD (Beauregard & Levesque, 2006). Fifteen children were trained to reduce 4 to 7 
Hz power at Cz while enhancing power in the 12 to 15 Hz and 15 to 18 Hz frequency ranges. 
After neurofeedback training participants in the neurofeedback group showed significant 
loci of activation in brain systems mediating selective attention and response inhibition 
compared to the control group that had no neurofeedback training. The results of this study 
suggest that neurofeedback has the capacity to functionally normalize brain systems in 
children with ADHD.  
Sterman theorized on possible neuronal mechanisms underlying the effects of 
neurofeedback targeting SMR (Sterman, 1996; Sterman & Egner, 2006). SMR is a 12 to 15 Hz 
rhythm that is found maximal over the sensorimotor cortex of the brain. SMR was found 
positively associated with control over excitation in the thalamocortical somatosensory and 
somatomotor pathways of the brain (Sterman, 1996; Sterman & Egner, 2006). By repeatedly 
producing increased amounts of SMR, postsynaptic cells may become more sensitive and 
consequently the probability of future activation of these cells may be increased. By 
increasing thresholds for excitation, neurofeedback may have beneficial effects on severity 
and frequency of seizures in clients with epilepsy. In ADHD, similarly increased thresholds 
for excitation are believed to be responsible for reductions in cortical and thalamocortical 
hyper-excitability and accompanying reductions in impulsive tendencies. 
Less is known about the neuronal underpinnings of neurofeedback in individuals with 
autism. Although the autistic brain is an increasing topic of interest in scientific research 
(e.g. Brambilla, Hardan, Ucelli di Nemic, Perez, Soares, & Barale, 2008), little research has 
been conducted on the actual consequences of neurofeedback in autism. Studies 
investigating the EEGs of individuals with autism have revealed abnormal patterns of EEG 
activity as compared to healthy controls. For example, individuals with autism showed 
diminished frontal and occipital/parietal alpha power (e.g. Chan, Sze, & Cheung, 2007; 
Murias et al., 2007) and increased phase consistency between posterior-frontal and anterior-
temporal brain areas as compared to healthy controls (e.g., Coben & Padolsky, 2007; Murias 
et al., 2007). Furthermore, elevated delta and theta power over frontal or fronto-central areas 
have been found in individuals with autism (e.g. Chan, Sze, & Cheung, 2007; Kouijzer et al., 
2009b; Kouijzer et al., 2010; Kouijzer et al., under review; Murias, Webb, Greenson, & 
Dawson, 2007). Kouijzer and colleagues (2009b; 2010) found reductions in autistic symptoms 
and improvements in executive functions in accordance with reductions in frontomedial 
theta power following neurofeedback training. Theta is typically located to the medial 
prefrontal cortex (MPFC) including the anterior cingulate cortex (ACC; Tsujimoto, Shimazu, 
& Isomura, 2006) and is inversely related to BOLD (blood-oxygen-level dependence) 
activation in these structures (Meltzer, Negishi, Mayes, & Constable, 2007). As such, 
neurofeedback mediated reductions in frontomedial theta power may be directly 
responsible for improvement in executive functioning and social cognitive abilities, 
functions that are typically associated with activation of the MPFC  (Bush, Luu, & Posner, 
2000; Di Martino et al., 2009; Henderson et al., 2006; Mundy, 2003; Ohnishi et al., 2000).  
5. Efficacy of neurofeedback in autism  
Currently, about 10 scientific publications have reported on the efficacy of neurofeedback in 
autism. Table 1 provides an overview of the studies that investigated the effects of 
neurofeedback in autism. Some studies described the effects of neurofeedback in one or 
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more participants (Scolnick, 2005; Sichel, Fehmi, & Goldstein, 1995; Thompson, Thompson, 
& Reid, 2010), whereas other studies compared a group of participants that had 
neurofeedback with a group of participants that had no neurofeedback or another treatment 
(Coben & Padolsky, 2007; Jarusiewicz, 2002; Kouijzer et al., 2009b; Kouijzer et al., 2010; 
Kouijzer et al., under review). Furthermore, in all studies to date, the participants were 
either children or adolescents. No studies of neurofeedback in adults with autism have been 
published at this time. About 88% of the participants in all studies that have been published 
were male. In terms of the autistic spectrum, most studies included participants with a 
diagnosis autism, Asperger syndrome or PDD-NOS. One study focused on participants with 
PDD-NOS only (Kouijzer et al., 2009b), whereas two other studies mainly included 
individuals with Asperger syndrome (Scolnick, 2005; Thompson, Thompson, & Reid, 2010). 
This paragraph will provide a detailed description of the outcomes of studies investigating 
the effects of neurofeedback with a consecutive focus on (1) behavioral symptoms as 
reported by parents and teachers, (2) cognitive functions, and (3) the EEG. The paragraph 
ends with discussing the long-term maintenance of effects of neurofeedback. 
Neurofeedback was found to positively affect autistic symptoms, such as social interaction 
problems and communication deficits (Coben & Padolsky, 2007; Kouijzer et al., 2009b; 
Kouijzer et al., 2010; Sichel, Fehmi, & Goldstein, 1995). In addition, improvement in self-
esteem, empathy, and flexibility were seen, as well as reductions of anxiety, temper tantrums, 
and mood changes (Scolnick, 2005). These positive effects of neurofeedback were all reported 
by parents who filled out questionnaires inquiring about their children’s behavior (Coben & 
Padolsky, 2007; Jarusiewicz, 2002; Kouijzer et al., 2009b; Kouijzer et al., 2010; Thompson, 
Thompson, & Reid, 2010) or reflected the outcomes of parent interviews (Jarusiewicz, 2002; 
Scolnick, 2005; Sichel, Fehmi, & Goldstein, 1995). In one study, neurofeedback did not result in 
a reduction of autistic symptoms (Kouijzer et al., under review). The reason why some studies 
did find positive effects of neurofeedback on symptom reduction in autism while other studies 
did not is unclear at this time. Kouijzer and colleagues (under review) suggested that 
differences in neurofeedback protocols and in sample characteristics between studies may 
have been responsible for such varying study outcomes. Another possibility may be that 
variations in study design and thus in the degree of control for nonspecific effects (e.g. the 
attention that is received by trainees in addition to their training) are responsible. More 
information about the effects of nonspecific factors and related design issues is provided in the 
subsequent paragraph entitled ‘Quality of neurofeedback research’. 
In contrast to the reports of parents, teachers did not report as much improvement in social 
interactions and communication skills. At the same time, the observations of teachers were 
included in only three studies (Kouijzer et al., 2010; Kouijzer et al., under review; Scolnick, 
2005). In one of these three studies, teachers reported improvement in behavior of 
adolescents with autism following neurofeedback (Scolnick, 2005). That is, in four out of five 
cases that were described in this paper, teachers noticed the same behavioral improvement 
as parents, such as improvement in self-esteem, flexibility, and empathy and reductions in 
anxiety and temper tantrums. In one case described in this paper, no changes in behavior 
were reported by the teacher, whereas the parents of that participant did report 
improvement. In two other studies that investigated teacher reports, teachers did not report 
any improvement in the behavior of children and adolescents following neurofeedback 
(Kouijzer et al., 2010; Kouijzer et al., under review).  
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Authors and year of 
publication 
n Study design 
Age 
range 
(years)
Treatment 
Number 
of 
sessions 
Sichel, Fehmi, & 
Goldstein, 1995 
1 Case study 8 
Decrease 4-8 Hz; increase 12-15 
Hz; P3, Pz, and P4 
31 
Jarusiewicz, 2002 24 
Pretest posttest 
control group 
4-13 
Decrease 2-7 Hz and 22-30 Hz; 
increase 10-13 Hz; C4 
20-69 
Scolnick, 2005 5 Case study 12-16 
Decrease 2-10 Hz and 22-30 Hz; 
increase 8-11 Hz, 12-15 Hz or 15-
18 Hz; Fz, Cz, Pz, C4 or T6 
24-31 
Coben & Padolsky, 
2007 
49 
Pretest posttest 
control group 
3-14 Decrease hyperconnectivity 20 
Kouijzer, de Moor, 
Gerrits, Congedo, & 
van Schie, 2009 
14 
Pretest posttest 
control group 
8-12 
Decrease 4-7 Hz; increase 12-15 
Hz; C4 
40 
Kouijzer, van Schie, 
de Moor, Gerrits, & 
Buitelaar, 2010 
20 
Randomized pretest 
posttest control group
8-12 
Decrease 3-7 Hz and slight 
variations; Fz, Cz or F4 
40 
Thompson, 
Thompson, & Reid, 
2010 
159 Case study 5-58 
Decrease 3-7 Hz; increase 12-15 
Hz; Cz or CFz 
40-60 
Kouijzer, van Schie, 
Gerrits, Buitelaar, & 
de Moor, under 
review 
38 
Randomized pretest 
posttest control group 
with blinded active 
comparator 
12-18 
Decrease 2-7 Hz and slight 
variations; Cz or CFz 
23-40 
Table 1. Overview of the studies that investigated the effects of neurofeedback in children 
and adolescents with autism.  
Neurofeedback was demonstrated to have positive effects on cognitive functions of children 
and adolescents with autism (Coben & Padolsky, 2007; Kouijzer et al., 2009b; Kouijzer et al., 
2010; Kouijzer et al., under review). These effects were measured by a series of 
neuropsychological tasks, which allow a more objective evaluation of the treatment effects 
than asking parents or teachers what they observed in the behavior of their child or student. 
A specific cognitive function that was found to be improved after neurofeedback treatment 
is cognitive flexibility. In three studies, improvement in cognitive flexibility was found in 
participants who received neurofeedback, whereas participants in the control groups 
showed no improvement in cognitive flexibility (Kouijzer et al., 2009b; Kouijzer et al., 2010; 
Kouijzer et al., under review). Cognitive flexibility is defined as the ability to shift to a 
different thought or action according to situational changes (Hill, 2004). Poor flexibility is 
one of the core characteristics of everyday behavior of individuals with autism and is often 
illustrated by a need for sameness. For example, many people with autism have difficulties 
in switching from one situation to the other or panic if an unexpected event occurs. The 
positive effects of neurofeedback on cognitive flexibility were found in studies that used the 
trail making task, which requires the participant to connect letters of the alphabet and 
numbers in an alternating manner (1-A-2-B-3-C, etc.) on paper. Whether neurofeedback also 
results in improvement in cognitive flexibility in real life is unknown at this time. Future 
studies may investigate if the effects of neurofeedback extend to real life conditions. For 
example by measuring the response of participants with autism in real life scenarios that 
require cognitive flexibility skills, e.g. a last minute change in schedule. In addition to 
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changes in cognitive flexibility, studies have reported improvements in other cognitive 
domains. Kouijzer and colleagues (2009b) noted additional improvements in attention, 
inhibition, and planning, suggesting a more general improvement in executive functions. 
This finding is supported by Coben and Padolsky (2007) who found a general improvement 
in executive functions accompanied by improvement in visual perceptual functioning and 
language skills following neurofeedback treatment.    
Another relatively objective way to evaluate the effects of neurofeedback training is QEEG. 
Since neurofeedback focuses on the change of electrical brain activity, QEEG measures may 
be used to examine whether the treatment actually influenced the EEG in a structural 
manner or not. Most studies that examined the effects of neurofeedback in children and 
adolescents with autism compared pre- and post-treatment QEEGs and found that EEG 
activity changed after neurofeedback. The specific effects in EEG depended on the 
neurofeedback protocol that was used. After inhibiting theta power and rewarding beta 
power, the theta to beta ratios of participants decreased, i.e. changed in the direction of 
normality on a post treatment measurement (Sichel, Fehmi, & Goldstein, 1995; Scolnick, 
2005; Thompson, Thompson, & Reid, 2010). Similarly, neurofeedback that focused on the 
inhibition of theta power resulted in decreased theta power (Kouijzer et al., 2010) and 
neurofeedback that aimed to decrease delta and theta power resulted in decreased delta 
power in subsequent QEEG measurements (Kouijzer et al., under review). A study by 
Coben and Padolsky (2007) was successful in reducing hyperconnectivity in most 
participants through the application of neurofeedback. Only one study failed to show effects 
in the EEGs of children and adolescents with autism who received neurofeedback (Kouijzer 
et al., 2009b). 
The positive effects on autistic symptoms, cognitive flexibility, and EEG activity that were 
found after neurofeedback are only clinically significant if they are maintained after 
treatment has ended. That is, if participants would return to pre-treatment levels after the 
last neurofeedback session, they should continue neurofeedback training for the rest of their 
lives in order to benefit from its effects. This would be comparable with the structural use of 
medication for reducing behavioral problems that are co-occurring with autism. Aggressive 
behavior, for example, can be reduced by the use of atypical antipsychotics (McCracken et 
al., 2002) and overactivity or disruptive behavior has been decreased with stimulants 
(Research Units on Pediatric Psychopharmacology, 2005). When the intake of such 
medication is interrupted, the beneficial effects typically disappear and symptoms return to 
earlier levels. On the basis of current evidence, however, it appears that neurofeedback in 
individuals with autism has long term effects on autistic symptoms and leads to long term 
improvement in cognitive functions. Kouijzer and colleagues used follow-up measures of 
autistic symptoms and cognitive functions either six months (Kouijzer et al., 2010; Kouijzer 
et al., under review) or twelve months (Kouijzer et al., 2009a) after the last neurofeedback 
session was completed. In one study, the effects in EEG theta activity were found to be 
maintained six months after neurofeedback treatment had ended (Kouijzer et al., 2010), 
whereas another study found that the initial changes in EEG delta activity that were found 
directly after the treatment had returned to baseline after six months (Kouijzer et al., under 
review). The reason why EEG changes were long lasting in one study but not in the other 
study might be related to the different samples that were used in these studies. The former 
study included participants of 8 to 12 years old and a broad range of behavioral problems, 
whereas the latter study included participants of 12 to 18 years old with mainly 
internalizing problems. Perhaps EEG changes in younger participants or in participants 
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with both externalizing and internalizing behavior problems are more likely to remain over 
time as compared to EEG changes in older participants or in participants with internalizing 
behavior problems. Although the changes in EEG activity were not maintained after six 
months in the study of Kouijzer and colleagues (under review), the positive effects on 
cognitive flexibility skills that co-occurred after neurofeedback were found to be maintained 
six months later. This suggests that long term changes in EEG are no requirement for 
structural improvements in cognitive flexibility. Perhaps a reduction of slow wave power is 
required for the initiation of cognitive flexibility improvement, whereas continuation of the 
ability for task switching relies on other mechanisms.  
6. Quality of neurofeedback research 
The efficacy of any treatment program in any specific population can be investigated by 
experimental research. Such experimental research should meet a number of criteria in 
order to prevent the study outcomes from being influenced by other factors than the 
treatment itself. Campbell and Stanley (1963) recommended the use of a pretest-posttest 
control group design to control for factors that might produce effects confounded with the 
effects of the experimental treatment such as maturation. In such a randomized pretest-
posttest control group design, participants are randomly allocated in two research groups: a 
treatment group that receives the treatment of interest and a control group that does not 
receive the treatment. Participants of both groups are assessed at comparable times before 
and after treatment. The results of the two groups at both times are compared in order to 
find effects of the treatment. Of the studies that investigated the effects of neurofeedback in 
individuals with autism, only two studies used random allocation of participants in 
treatment and control groups (Kouijzer et al., 2010; Kouijzer et al., under review), compared 
to six studies that did not. 
Several authors have suggested that the outcomes of previous studies that investigated the 
effects of neurofeedback were not a result of neurofeedback per se, but rather reflected 
nonspecific effects of neurofeedback. Nonspecific treatment effects are positive effects that 
are caused by other factors than the treatment of interest. In the case of neurofeedback, 
implicit attention training and intensive one-to-one contact with the therapist might 
positively affect the results of the treatment. Neurofeedback is a treatment that includes 
many sessions that are provided twice or thrice a week. In each of these sessions, the client 
is instructed to focus his or her attention on the computer screen in front of him or her. 
Several authors have suggested that participants might be positively affected by being 
involved in such an intensive treatment that requires paying sustained attention to a 
computer screen (Gevensleben et al., 2009; Heinrich, Gevensleben, & Strehl, 2007; Kouijzer 
et al., 2010). Furthermore, the long-duration of neurofeedback typically implies intensive 
one-to-one contact between client and therapist. Therapists pay individual attention to the 
client and provide warmth, empathy, and acceptance. Furthermore, the contact between 
client and therapist in neurofeedback sessions has a highly structured character because it 
often follows a fixed program of alternating training and rest intervals. These factors might 
be especially important in individuals with autism, who often have difficulties in building a 
relationship with unfamiliar others. Because neurofeedback offers so many opportunities for 
the development of the relationship between client and therapist in a structured and 
predictable environment, there is a good chance for the client with autism to successfully 
participate in a reciprocal relationship with the therapist. This experience might cause 
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improvement in the social behavior of participants that is unrelated to improvement as a 
result of neurofeedback training (Gevensleben et al., 2009; Heinrich, Gevensleben, & Strehl, 
2007; Kouijzer et al., 2010). In order to control for such nonspecific effects of neurofeedback, 
a control condition in which participants receive similar amounts of attention training and 
one-to-one contact with the therapist should be included in the research design.   
Another factor that might have played a role in studies that investigated the effects of 
neurofeedback is treatment expectancy of participants and their parents. The notion of 
receiving therapy is known to generate expectancy for improvement in participants and 
their parents (Borkovec & Nau, 1972). Especially if parents have invested time and money in 
the treatment of their child, these parents may have been inclined towards a positivity bias 
that matches their investments. Several authors have suggested that the outcomes of 
previous studies that measured behavioral improvement with parent questionnaires could 
have been affected by expectancy biases of parents (Gevensleben et al., 2009; Heinrich, 
Gevensleben, & Strehl, 2007; Kouijzer et al., 2010). In order to control for the effects of 
expectancy, the expectancy of parents and participants should be measured in each study 
that evaluates the effects of neurofeedback.  
Only one study fully controlled for the nonspecific effects of implicit attention training, one-
to-one contact between client and therapist, and treatment expectancy (Kouijzer et al., under 
review). In this study, an alternative treatment group was created next to the neurofeedback 
group and the waiting list control group. This alternative treatment was almost identical to 
neurofeedback training, except for the signal that was fed back to the participants. In the 
neurofeedback group, the EEG signal was fed back to the client, whereas in the alternative 
treatment group another bodily signal, i.e. the skin conductance (SC) signal, was fed back. 
Participants and their parents were blinded and thus not informed about the signal that was 
used during their training. The participants of the SC group were expected to improve in 
relaxation and calmness as an effect of the SC training, but not to show reductions in 
symptoms of autism and to improve in cognitive functions and EEG as much as the 
participants in the neurofeedback group.  
Another option to control for the nonspecific effects of neurofeedback is to use a double-
blind placebo controlled study design. Such a study includes one group that receives the 
treatment of interest and one group that receives a placebo treatment. In the case of 
neurofeedback, the placebo treatment could include fake feedback that is unrelated to the 
participants’ brain activity. Neither participants nor therapists are aware of the type of 
feedback that is provided to the participants. For neurofeedback, however, such a design is 
hard to realize for three reasons. First of all, both the therapist and the participants in the 
placebo group are likely to discover that the fake feedback is unrelated to the participants’ 
EEG activity. Secondly, high drop-out rates have been found in placebo groups where 
participants were unable to gain any control over the EEG signal (Orlandi & Greco, 2005). 
Finally, patients often do not want to take the risk of receiving placebo training for so many 
sessions and therefore it is hard to include large numbers of participants in double-blind 
controlled studies. An alternative for placebo feedback is mock-feedback. This training 
method takes care of extreme situations in which the participant produces extreme muscle 
activity or in which the electrode detaches from the scalp. The use of mock-feedback 
dramatically increases the reliability of the feedback and is thus more appropriate to apply 
in studies evaluating the effects of neurofeedback. 
Because most studies that investigated the effects of neurofeedback in children and 
adolescents with autism did not fully control for the nonspecific effects of neurofeedback, 
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there is a high need for further research that does control for such effects. Therefore, 
conclusions on the efficacy of neurofeedback for individuals with autism can only be drawn 
after several such studies have been conducted. Until then, the conclusions of the studies 
that investigated the effects of neurofeedback should be taken cautiously.   
Another aspect that needs attention in future research concerns the treatment protocols that 
are used in neurofeedback. So far, most neurofeedback studies focused on the reduction of 
theta power with or without the reward of low beta power (Jarusiewicz, 2002; Kouijzer et 
al., 2009b; Kouijzer et al., 2010; Kouijzer et al., under review; Scolnick, 2005; Sichel, Fehmi, & 
Goldstein, 1995; Thompson, Thompson, & Reid, 2010). Furthermore, Coben and Padolsky 
(2007) used an original approach to use a neurofeedback protocol directed at the 
normalization of coherence between two or more brain areas. The different treatment 
outcomes of these and other neurofeedback protocols have not been investigated 
systematically. It might turn out that some treatment protocols work best for a specific 
group of individuals with autism, whereas other treatment protocols are most effective for a 
group of individuals with other characteristics.  
A final challenge for future research concerns the identification of responders to 
neurofeedback. As mentioned earlier in this chapter, some individuals with autism respond 
well to neurofeedback and are able to change EEG activity during neurofeedback sessions, 
whereas other individuals do not respond and elicit no EEG changes. Importantly, a recent 
study (Kouijzer et al., under review) demonstrated that the benefits of neurofeedback only 
take place in individuals with autism who respond to neurofeedback. It is therefore of 
crucial importance to identify responders to neurofeedback in an early stage or even better, 
before treatment starts. Future research should identify demographic, psychological or 
physiological characteristics of individuals who respond to neurofeedback.  
7. Future developments in neurofeedback  
Neurofeedback as a treatment for clients with various disorders has rapidly expanded in the 
past years, due to increasing technological developments which made the registration of 
EEG activity more accurate and available for therapists. Next to the traditional 
neurofeedback as described previously in this chapter, several other modalities of 
neurofeedback have been developed. In the next section three of these recent developments 
are discussed, i.e. LORETA-neurofeedback, ICA-neurofeedback, and fMRI-neurofeedback. 
LORETA refers to low resolution tomography and is an inverse technique for reconstructing 
the source of EEG activity in the three-dimensional brain by electrophysiological models. In 
LORETA-neurofeedback, feedback reflects EEG activity that is generated by a specific 
source, which deviates from traditional neurofeedback approaches where feedback reflects 
spatially nonspecific EEG activity at the sensor level (Congedo, 2003). LORETA-
neurofeedback can not be applied in real time, because of time and capacity consuming 
calculations of the computer. Therefore, LORETA-neurofeedback is applied by using a 
spatial filter after the EEG activity is recorded. LORETA-neurofeedback can be used to alter 
EEG activity generated in deep brain structures that can not be recorded accurately by 
traditional neurofeedback. In a study by Congedo, Lubar, and Joffe (2004) the application of 
LORETA-neurofeedback was investigated in six healthy students. These participants were 
trained to decrease beta power and to concurrently increase alpha power generated in the 
ACC. The results of this study show an increased beta/alpha ratio in the regions of the ACC 
that were involved in the LORETA-neurofeedback (Congedo, Lubar, & Joffe, 2004). These 
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findings suggest that EEG activity in specific brain areas may be altered by LORETA-
neurofeedback.  
Related to LORETA-neurofeedback is ICA-neurofeedback. ICA refers to independent 
component analysis and is a mathematical approach that separates a multivariate signal in 
independent components. In the case of ICA-neurofeedback, ICA separates the raw EEG 
signal in separate sources of the signal. This technique can be applied in cases where 
neurofeedback focuses on specific EEG components that can not be detected easily from the 
raw EEG signal by traditional neurofeedback devices. ICA- and LORETA-neurofeedback 
can be used interchangeably, but are not similar. ICA-neurofeedback uses mathematical 
models to calculate the solutions of the EEG signal, whereas LORETA-neurofeedback is 
based on electrophysiological models.  
A third modality of neurofeedback is fMRI-neurofeedback. FMRI-neurofeedback is an 
advanced method that uses the BOLD response of regions in the brain. FMRI is a technique 
that allows measurements of brain activity with a high spatial resolution, but low temporal 
resolution, as compared to EEG which has a high temporal resolution, but is limited in the 
spatial domain. At this time, fMRI-neurofeedback is mainly used in research settings and is 
hardly applied in the treatment of clinical populations. The main reason for this is that fMRI 
is an expensive technique and that any treatment application will suffer from a long time 
delay, which lies in the order of several seconds, resulting from the sluggishness of the 
BOLD response. This delay in feedback makes it especially hard for individuals to relate the 
feedback to the actual brain activity. Nevertheless, DeCharms and colleagues (2004) 
successfully applied fMRI-neurofeedback in six healthy participants. They were instructed 
to imagine hand movements while trying to optimize their strategy to increase activation in 
a brain area involved in this cognitive process, i.e. the sensorimotor cortex. The participants 
received continuous information about the strength of activation they were producing in 
their sensorimotor cortex. After three sessions, participants succeeded in controlling task-
specific activation in the sensorimotor cortex.  
LORETA-neurofeedback, ICA-neurofeedback, and fMRI-neurofeedback are examples of 
recent developments in the field of neurofeedback that are expected to gain further scientific 
interest over the coming years. These techniques hold the potential for changing activation 
in specific neural regions using neurofeedback. As such, it is more than likely that the 
clinical application of EEG neurofeedback in the coming years will develop in the direction 
of EEG source modeling techniques (such as LORETA- and ICA-neurofeedback) to allow the 
activation or deactivation of specific neural structures that are implicated in neurological 
conditions such as autism. FMRI-neurofeedback on the other hand may prove a valuable 
experimental technique for assisting cognitive neuroscience in its aim to uncover the 
functional organization of the brain.  
8. Conclusion  
Neurofeedback is a technique that is used to alter activity of the brain that deviates from 
normality in a variety of clinical disorders, such as autism. Recent findings suggest that 
neurofeedback may provide a beneficial treatment for individuals in the autism spectrum. 
Indeed several studies have shown that individuals with autism are able to alter their brain 
activity in specific frequency bands through the use of neurofeedback and that 
neurofeedback training may be accompanied by prolonged changes in autism symptoms, 
cognitive functioning and long-term changes in EEG. Although the prospects for the 
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application of neurofeedback in autism spectrum disorders certainly look promising, the 
scientific evidence for its effectiveness to date is still rather thin. Future studies will have to 
be conducted using larger samples and appropriate control conditions to allow reliable 
measures of the efficacy of neurofeedback treatment in autism both in the lab and in clinical 
practice.  
9. References 
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders, 
text revision (4th ed.).  Washington, DC: American Psychiatric Association. 
Arns, M., de Ridder, S., Strehl, U., Breteler, M., & Coenen, A. (2009). Efficacy of 
neurofeedback treatment in ADHD: the  effects on inattention, hyperactivity, and 
impulsivity: a meta-analysis. Clinical EEG and Neuroscience, 40 (3), 179- 189. 
Bair, J.H. (1901). Development of voluntary control. Psychological review, 8, 474-510. 
Beauregard, M & Lévesque, J. (2006). Functional Magnetic Resonance Imaging Investigation 
of the Effects of  Neurofeedback Training on the Neural Bases of Selective Attention 
and Response Inhibition in Children with  Attention-Deficit/Hyperactivity 
Disorder. Applied Psychophysiology and Biofeedback, 31,(1), 3-20. 
Birbaumer, N., Ghanayim, N., Hinterberger, T., Iversen, I., Kotchoubey, B., Kübler, A., 
Perelmouter, J., Taub, E., & Flor,  H. (1999). A spelling device for the paralysed. 
Nature, 398, 297-298. 
Borkovec, T.D. & Nau, S.D. (1972). Credibility of analogue therapy rationales. Journal of 
Behavior Therapy &  Experimental Psychiatry, 3, 257-260. 
Brambilla, P., Hardan, A., Ucelli di Nemic, S., Perez, J., Soares, J.C., & Barale, F. (2008). Brain 
anatomy and  development in autism: review of structural MRI studies. Brain 
research bulletin, 61, 557-569. 
Bush, G., Luu, P., & Posner, M. I. (2000). Cognitive and emotional influences in anterior 
cingulate cortex. Trends in  Cognitive Science, 4, 215–222. 
Campbell, D.T. & Stanley, J.C. (1963). Experimental and quasi-experimental designs for research. 
Chicago, llinois: Rand  McNally. 
Chan, A.S., Sze, S.L., & Cheung, M. (2007). Quantitative Electroencephalographic Profiles for 
Children With Autistic  Spectrum Disorder. Neuropsychology, 21 (1), 74-81. 
Cherkassky, V. L., Kana, R. K., Keller, T. A., & Just, M. A. (2006). Functional connectivity in a 
baseline resting-state  network in autism. Neuroreport, 17, 1687–1690. 
Coben, R. & Padolsky, I. (2007). Assessment-guided neurofeedback for autistic spectrum 
disorders. Journal of  Neurotherapy, 11, 5-23.  
Congedo, M. (2003). Tomographic neurofeedback; a new technique for the self-regulation of brain 
electrical activity. Thesis, Knoxville, TN: The university of Tennessee, Knoxville.  
Congedo, M. Lubar, J.F., & Joffe, D. (2004). Low-resolution electromagnetic tomography 
neurofeedback. Neural systems  and rehabilitation engineering, 12 (4), 387-397.  
DeCharms, R.C., Christoff, K., Glover, G.H., Pauly, J.M., Whitfield, S., & Gabrieli, J.D.E. 
(2004). Learned regulation of  spatially localized brain activity using real-time fmri. 
Neuroimage, 21(1), 436-443.  
Di Martino, A., Ross, K., Uddin, L. Q., Sklar, A. B., Castellanos, F. X., & Milham, M. P. (2009). 
Functional brain  correlates of social and nonsocial processes in autism spectrum 
disorders: An activation likelihood estimation  meta-analysis. Biological Psychiatry, 
65, 63–74. 
www.intechopen.com
Neurofeedback Treatment 
for Autism Spectrum Disorders – Scientific Foundations and Clinical Practice 
 
121 
Gazzaniga, M.S. & Heatherton, T.F. (2003). Psychological Science. New York: W.W. Norton & 
Company.  
Gevensleben, H.,  Holl, B., Albrecht, B., Vogel, C., Schlamp, D., Kratz, O., Studer, P., 
Rothenberger, A., Moll, G.H., & Heinrich, H.. (2009). Is neurofeedback an 
efficacious treatment for ADHD? A randomised controlled clinical  trial. Journal of 
Child Psychology and Psychiatry, 50 (7), 780-789. 
Greenwald, A.G. (1970). A choice reaction time test of ideomotor theory. Journal of 
Experimental Psychology, 86, 20-25. 
Heinrich, H., Gevensleben, H., & Strehl, U. (2007). Annotation: Neurofeedback—train your 
brain to train behavior.  Journal of Child Psychology and Psychiatry, 48(1), 3–16. 
Henderson, H., Schwartz, C., Mundy, P., Burnette, C., Sutton, S., Zahka, N., et al. (2006). 
Response monitoring, the  error-related negativity, and differences in social 
behavior in autism. Brain and Cognition, 61, 96–109. 
Hill, E.L. (2004). Executive dysfunctions in autism. Trends in cognitive sciences, 8 (1), 26-32. 
Jarusiewicz, B. (2002). Efficacy of neurofeedback for children in the autistic spectrum: A 
pilot study. Journal of  Neurotherapy, 6, 39–49. 
Kamiya, J. (1968). Conscious control of brain waves. Psychology Today, 1, 57-60. 
Kennedy, D. P., & Courchesne, E. (2008). The intrinsic functional organization of the brain is 
altered in autism.  NeuroImage, 39, 1877–1885. 
Kouijzer, M.E.J., de Moor, J.M.H., Gerrits, B.J.L., Buitelaar, J.K., & van Schie, H.T. (2009b). 
Long-term effects of  neurofeedback treatment in autism. Research in Autism 
Spectrum Disorders, 3, 496-501.   
Kouijzer, M.E.J., de Moor, J.M.H., Gerrits, B.J.L., Congedo, M., & van Schie, H.T. (2009a). 
Neurofeedback improves  executive functioning in children with autism spectrum 
disorders. Research in Autism Spectrum Disorders, 3, 145- 162. 
Kouijzer, M.E.J., van Schie, H.T., de Moor, J.M.H., Gerrits, B.J.L., & Buitelaar, J.K. (2010). 
Neurofeedback treatment in  autism. Preliminary findings in behavioral, cognitive, 
and neurophysiological functioning. Research in  Autism Spectrum Disorders, 4, 386-
399.  
Kouijzer, M.E.J., van Schie, H.T., Gerrits, B.J.L, Buitelaar, J.K., & de Moor, J.M.H. (under 
review). Is EEG-biofeedback an  Effective Treatment For Autism? A Randomized 
Controlled Trial. 
Kropotov, J.D.,  Grin-Yatsenko, V.A., Ponomarev, V.A., Chutko, L.S., Yakovenko, E.A., & 
Nikishena, I.S. (2005). ERPs  correlates of EEG relative beta training in ADHD 
children. International journal of psychophysiology, 55, 23-34.  
Lubar, J. F., & Shouse, M. N. (1976). EEG and behavioral changes in a hyperkinetic child 
concurrent with training of  the sensorimotor rhythm (SMR): A preliminary report. 
Biofeedback and Self Regulation, 3, 293-306. 
McCracken, J.T., McGough, J., Shah, B. Cronin, P., Hong, D., Aman, M.G., et al. (2002). 
Risperdone in children with  autism and serious behavioral problems. New England 
journal of medicine, 5, 314-321.  
Meltzer, J. A., Negishi, M., Mayes, L. C., & Constable, R. T. (2007). Individual differences in 
EEG theta and alpha  dynamics during working memory correlate with fMRI 
responses across subjects. Clinical Neurophysiology, 118,  2419–2436. 
Monastra, V.J., Lynn, S., Linden, M., Lubar, J.F., Gruzelier, J., & LaVaque, T.J. (2005). 
Electroencephalographic Biofeedback in the Treatment of Attention-
www.intechopen.com
 Autism Spectrum Disorders – From Genes to Environment 
 
122 
Deficit/Hyperactivity Disorder. Applied Psychophysiology and Biofeedback, 30 (2), 95-
114. 
Mundy, P. (2003). Annotation: The neural basis of social impairments in autism: The role of 
the dorsal medial-frontal  cortex and anterior cingulate system. Journal of Child 
Psychology and Psychiatry, 44, 793–809. 
Murias, M., Webb, S. J., Greenson, J., & Dawson, G. (2007). Resting state cortical connectivity 
reflected in EEG  coherence in individuals with autism. Biological Psychiatry, 62, 
270–273. 
Ohnishi, T., Matsuda, H., Hashimoto, T., Kunihiro, T., Nishikawa, M., Uema, T., et al. (2000). 
Abnormal regional  cerebral blood flow in childhood autism. Brain, 123, 1838–1844. 
Orlandi, M.A. & Greco, D. (2005). A randomized, double-blind clinical trial of EEG neurofeedback 
treatment for attention  deficit/hyperactivity disorder (ADHD). In ISNR conference.  
Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. 
L. (2001). A default mode  of brain function. Proceedings of the National Academy of 
Sciences, 98, 676–682. 
Research Units on Pediatric Psychopharmacology (2005). Randomized, controlled, crossover 
trial of methylphenidate  in pervasive developmental disorders with hyperactivity. 
Archives of general psychiatry, 62, 1266-1274.  
Scolnick, B. (2005). Effects of electroencephalogram biofeedback with Asperger’s syndrome. 
International Journal of  Rehabilitation Research, 28, 159–163. 
Sichel, A. G., Fehmi, L. G., & Goldstein, D. M. (1995). Positive outcome with neurofeedback 
treatment in a case of mild  autism. Journal of Neurotherapy, 1 (1), 60-64.  
Sterman, M. B. (1996). Physiological origins and functional correlates of EEG rhythmic 
activities: Implications for self- regulation. Biofeedback and Self Regulation, 21, 3–33. 
Sterman, M.B. & Egner, T. (2006). Foundations and practice of neurofeedback for the 
treatment of epilepsy. Applied  Psychophysiology and Biofeedback, 31 (1), 21-35. 
Sterman, M. B., Macdonald, L. R. and Stone, R. K. (1974). Biofeedback Training of the 
Sensorimotor  Electroencephalogram Rhythm in Man: Effects on Epilepsy. Epilepsia, 
15, 395–416. 
Tan, G., Thornby, J., Hammond, D.C., Strehl, U., Canady, B., Arnemann, K., & Kaiser, D.A. 
(2009). Meta-analysis of  EEG-biofeedback in treating epilepsy. Clinical EEG and 
Neuroscience, 40 (3), 1-7. 
Thompson, L., Thompson, M., & Reid, A. (2010). Neurofeedback Outcomes in  Clients with 
Asperger’s Syndrome.  Applied Psychophysiology and Biofeedback, 35, 63-81. 
Thorndike, E.L. (1933). A proof of the law of effect. Science, 77, 173. 
Tsujimoto, T., Shimazu, H., & Isomura, Y. (2006). Direct recording of theta oscillations in 
primate prefrontal and  anterior cingulate cortices. Journal of Neurophysiology, 95, 
2987–3000. 
Wyricka, W. & Sterman, M.B. (1968). Instrumental conditioning of sensorimotor cortex EEG 
spindles in the waking cat.  Physiology and Behavior, 3, 703-707. 
Yucha, C. & Montgomery, D. (2008).Evidence-Based Practice in Biofeedback and Neurofeedback. 
Wheat Ridge, CO:  Association for Applied Psychophysiology and Biofeedback. 
www.intechopen.com
Autism Spectrum Disorders - From Genes to Environment
Edited by Prof. Tim Williams
ISBN 978-953-307-558-7
Hard cover, 400 pages
Publisher InTech
Published online 06, September, 2011
Published in print edition September, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Autism spectrum disorders are a major topic for research. The causes are now thought to be largely genetic
although the genes involved are only slowly being traced. The effects of ASD are often devastating and
families and schools have to adapt to provide the best for people with ASD to attain their potential. This book
describes some of the interventions and modifications that can benefit people with ASD.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Mirjam E.J. Kouijzer, Hein T. van Schie, Berrie J.L. Gerrits, and Jan M.H. de Moor (2011). Neurofeedback
Treatment for Autism Spectrum Disorders – Scientific Foundations and Clinical Practice, Autism Spectrum
Disorders - From Genes to Environment, Prof. Tim Williams (Ed.), ISBN: 978-953-307-558-7, InTech, Available
from: http://www.intechopen.com/books/autism-spectrum-disorders-from-genes-to-
environment/neurofeedback-treatment-for-autism-spectrum-disorders-scientific-foundations-and-clinical-
practice
© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed
under the terms of the Creative Commons Attribution-NonCommercial-
ShareAlike-3.0 License, which permits use, distribution and reproduction for
non-commercial purposes, provided the original is properly cited and
derivative works building on this content are distributed under the same
license.
